FDA Approves Proteus Digital Health’s E-pills for Dose Monitoring An "ingestible sensor" doesn’t sound like the tastiest of snacks, but soon it might be just what the doctor ordered. A tiny microchip which activates upon contact with stomach acid has recently been approved by the FDA. When the sensor is …
Read More »HbA1c Greater than 6.5% Is Specific, Not Sensitive for T1DM Youth
Across four studies, HbA1c ≥ 6.5 percent a specific, but not sensitive, early indicator of T1D in youth….
Read More »Testosterone Therapy for Type 2’s Affected by Depression
Testosterone therapy may be useless in men with type 2 diabetes and hypogonadism who also have depression….
Read More »Love Handles Increase Risk of Death by 50% with Normal BMI
Where people store fat may ultimately determine their risk for developing diabetes and heart disease….
Read More »A1c Associated with Microalbuminuria
A1c variability is independently associated with the development of microalbuminuria in patients with type 2 diabetes….
Read More »Elevated Sugars Linked to Brain Shrinkage
People whose blood sugar is on the high end of the normal range may be at greater risk of brain shrinkage that occurs with aging and diseases such as dementia….
Read More »New Analysis Touts Low Carb Diets
A new analysis from Duke University found that those on a low carb diet lost 18 pounds….
Read More »Can Prediabetes Cause Neuropathy?
Neuropathy can be found developing eventually in approximately 50% of all diabetes patients. What about in prediabetes?…
Read More »Any Protein in Urine Can Signal Heart Risk
Even slightly elevated albumin was linked to raised odds of stroke, heart attack, heart failure….
Read More »Clopidogrel Not As Effective for the Diabetic Heart
A Danish registry study showed that patients with diabetes may not get as much benefit from clopidogrel (Plavix) for secondary prevention after a heart attack as nondiabetic patients….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.